Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. [electronic resource]
Producer: 20131029Description: 415-23 p. digitalISSN:- 1439-0973
- Amikacin -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Ciprofloxacin -- therapeutic use
- Drug Resistance, Multiple, Bacterial
- Drug Utilization -- statistics & numerical data
- Drug Utilization Review -- methods
- Hospitals -- standards
- Humans
- Imipenem -- therapeutic use
- Incidence
- Japan -- epidemiology
- Meropenem
- Microbial Sensitivity Tests
- National Health Programs
- Pseudomonas Infections -- drug therapy
- Pseudomonas aeruginosa -- drug effects
- Retrospective Studies
- Surveys and Questionnaires
- Thienamycins -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.